...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: RESVERLOGIX AND MEDISON PHARMA LTD. ANNOUNCE STRATEGIC LICENSING AGREEMENT
1
Jan 08, 2018 10:01PM
2
Jan 09, 2018 08:26AM
1
Jan 09, 2018 09:52AM
2
Jan 09, 2018 10:05AM
3
Jan 09, 2018 10:11AM
2
Jan 09, 2018 11:37AM
4
Jan 09, 2018 11:37AM
3
Jan 09, 2018 12:04PM
1
Jan 09, 2018 12:14PM
4
Jan 09, 2018 12:17PM
2
Jan 09, 2018 12:21PM
2
Jan 09, 2018 12:25PM
1
Jan 09, 2018 12:45PM
1
Jan 09, 2018 02:29PM

Tada

I dont know if RVX-208 can be marketed in Israel before Europe, but Europe, China, Japan & Israel will be marketing RVX before FDA approval and could lead to US fastracking the NDA. I agree, someone expert in trial protocol needs to chime in on this.

Chicagoest

Share
New Message
Please login to post a reply